Brain-Derived Neurotrophic Factor Is Essential for Opiate-Induced Plasticity of Noradrenergic Neurons

Journal of Neuroscience

Volumn 22, Issue 10, 2002, Pages 4153-4162

  Akbarian, Schahram ^a,b   Rios, Maribel ^a   Liu, Rong Jian ^c   Gold, Stephen J ^d   Fong, Hiu Fai ^a   Zeiler, Steve ^e   Coppola, Vincenzo ^f   Tessarollo, Lino ^f   Jones, Kevin R ^e   Nestler, Eric J ^d   Aghajanian, George K ^c   Jaenisch, Rudolf ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

BDNF; cAMP; Cre recombinase; Locus coeruleus; LoxP; Norepinephrine; Opiates; Plasticity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CYCLIC AMP; MORPHINE; OPIATE; TYROSINE 3 MONOOXYGENASE; CALMODULIN DEPENDENT PROTEIN KINASE II; CALMODULIN-DEPENDENT PROTEIN KINASE II; CRE RECOMBINASE; FORSKOLIN; INTEGRASE; MU OPIATE RECEPTOR; NARCOTIC AGENT; NORADRENALIN; PROTEIN KINASE (CALCIUM,CALMODULIN); VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; LOCUS CERULEUS; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WITHDRAWAL SYNDROME; ANIMAL; ANIMAL BEHAVIOR; CELL COUNT; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; GENETIC RECOMBINATION; GENETICS; GENOTYPE; HOSPITALIZATION; IN SITU HYBRIDIZATION; IN VITRO STUDY; METABOLISM; MOUSE MUTANT; NERVE CELL; PHYSIOLOGY; REPORTER GENE; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL COUNT; CYCLIC AMP; DOWN-REGULATION; FORSKOLIN; GENE DELETION; GENES, REPORTER; GENOTYPE; IN SITU HYBRIDIZATION; INTEGRASES; LOCUS COERULEUS; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; NARCOTICS; NEURONAL PLASTICITY; NEURONS; NOREPINEPHRINE; RECEPTORS, OPIOID, MU; RECOMBINATION, GENETIC; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME; TRANSGENES; TYROSINE 3-MONOOXYGENASE; VIRAL PROTEINS;

EID: 0037095689     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-10-04153.2002     Document Type: Article

References (69)

1. Aghajanian GK, Kogan JH, Moghaddam B (1994) Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res 636:126-130.
2. Akaoka H, Aston-Jones G (1991) Opiate withdrawal-induced hyperactivity of locus ceruleus neurons is substantially mediated by augmented excitatory amino acid input. J Neurosci 11:3830-3839.
3. Akbarian S, Bates B, Liu RJ, Skirboll SL, Peichal T, Coppola V, Sun LD, Fan G, Kucera J, Wilson MA, Tessarollo L, Kosofsky BE, Taylor JR, Bothwell M, Nestler EJ, Aghajanian GK, Jaenisch R (2001) Neurotrophin-3 modulates noradrenergic neuron function and opiate withdrawal. Mol Psychiatry 6:593-604.
4. Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, Lindsay RM, Wiegand SJ (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389:856-860.
5. Aston-Jones G, Rajkowski J, Cohen J (1999) Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46:1309-1320.
6. Bhattacharyya A, Watson FL, Bradlee TA, Pomeroy SL, Stiles CD, Segal RA (1997) Trk receptors function as rapid retrograde signal carriers in the adult nervous system. J Neurosci 17:7007-7016.
7. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720-723.
8. Boundy VA, Gold SJ, Messer CJ, Chen J, Son JH, Joh TH, Nestler EJ (1998) Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice. J Neurosci 18:9989-9995.
9. Caille S, Espejo EF, Reneric JP, Cador M, Koob GF, Stinus L (1999) Total neurochemical lesion of noradrenergic neurons of the locus coeruleus does not alter either naloxone-precipiated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp Ther 290:881-892.
10. Castren E, Thoenen H, Lindholm D (1995) Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience 64:71-80.
11. Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27:327-331.
12. Chieng B, Williams JT (1998) Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal. J Neurosci 18:7033-7039.
13. Christie MJ, Williams JT, Osborne PB, Bellchambers CE (1997) Where is the locus in opioid withdrawal? Trends Pharmacol Sci 18:134-140.
14. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S (1997) Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 17:2295-3213.
15. Conner JM, Lauterborn JC, Gall CM (1998) Anterograde transport of neurotrophin proteins in the CNS: a reassessment of the neurotrophic hypothesis. Rev Neurosci 1998:91-103.
16. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000) Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403:430-434.
17. Ernfors P, Lee KF, Jaenisch R (1994) Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368:147-150.
18. Fan G, Beard C, Chen RZ, Csankovszki G, Sun Y, Siniaia M, Biniszkiewicz D, Bates B, Lee PP, Kuhn R, Trumpp A, Poon C, Wilson CB, Jaenisch R (2001) DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals. J Neurosci 21:788-797.
19. Farinas I, Jones KR, Tessarollo L, Vigers AJ, Huang E, Kirstein M, de Caprona DC, Coppola V, Backus C, Reichardt LF, Fritzsch B (2001) Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J Neurosci 21:6170-6180.
20. Fawcett JP, Bamji SX, Causing CG, Aloyz R, Ase AR, Reader TA, McLean JH, Miller FD (1998) Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS. J Neurosci 18:2808-2821.
21. Finn AK, Whistler JL (2001) Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 32:829-839.
22. Friedman WJ, Ibanez CF, Hallbook F, Persson H, Cain LD, Dreyfus CF, Black IB (1993) Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Exp Neurol 119:72-78.
23. Grasing K, Bills D, Ghosh S, Schlussman SD, Patel AH, Woodward JJ (1997) Opiate modulation of striatal dopamine and hippocampal norepinephrine release following morphine withdrawal. Neurochem Res 22:239-248.
24. Guitart X, Hayward M, Nisenbaum LK, Beitner-Johnson DB, Haycock JW, Nestler EJ (1990) Identification of MARPP-58, a morphine- and cyclic AMP-regulated phosphoprotein of 58 kDa, as tyrosine hydroxylase: evidence for regulation of its expression by chronic morphine in the rat locus coeruleus. J Neurosci 10:2649-2659.
25. Hausdorff WP, Hnatowich M, O'Dowd BF, Caron MG, Lefkowitz RJ (1990) A mutation of the beta 2-adrenergic receptor impairs agonist activation of adenylyl cyclase without affecting high affinity agonist binding. Distinct molecular determinants of the receptor are involved in physical coupling to and functional activation of Gs. J Biol Chem 265:1388-1393.
26. Ivanov A, Aston-Jones G (2001) Local opiate withdrawal in locus coeruleus neurons in vitro. J Neurophysiol 85:2388-2397.
27. Jones KR, Farinas I, Backus C, Reichardt LF (1994) Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76:989-999.
28. Kalia M, Fuxe K, Goldstein M (1985) II. Rat medulla oblongata. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal processes. J Comp Neurol 233:308-332.
29. Kang H, Schuman EM (1995) Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 267:1658-1662.
30. Kang H, Schuman EM (2000) Intracellular Ca(2+) signaling is required for neurotrophin-induced potentiation in the adult rat hippocampus. Neurosci Lett 282:141-144,
31. Kang H, Welcher AA, Shelton D, Schuman EM (1997) Neurotrophins and time: different roles for TrkB signaling in hippocampal long-term potentiation. Neuron 19:653-664.
32. King VR, Michael GJ, Joshi RK, Priestley JV (1999) trkA, trkB, and trkC messenger RNA expression by bulbospinal cells of the rat. Neuroscience 92:935-944.
33. Klein R, Parada LF, Coulier F, Barbacid M (1989) TrkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO J 8:3701-3709.
34. Kogan JH, Nestler EJ, Aghajanian GK (1992) Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur J Pharmacol 211:47-53.
35. Kohara K, Kitamura A, Morishima M, Tsumoto T (2001) Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons. Science 291:2419-2423.
36. Konradi C, Heckers S (1995) Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein. Neuroscience 65:1051-1061.
37. Koob GF, Maldonado R, Stinus L (1992) Neural substrates of opiate withdrawal. Trends Neurosci 15:186-191.
38. Koob GF, Sanna PP, Bloom FE (1998) Neuroscience of addiction. Neuron 21:467-476.
39. Lane-Ladd SB, Pineda J, Boundy V, Pfeuffer T, Krupinski J, Aghajanian GK, Nestler EJ (1997) CREB in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17:7890-7901.
40. Liu J-G, Prather PL (2001) Chronic exposure to μ-opioid agonists produces constitutive activation of μ-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Mol Pharmacol 60:53-62.
41. Maisonpierre PC, Belluscio L, Friedman B, Alderson RF, Wiegand SJ, Furth ME, Lindsay RM, Yancopoulos GD (1990) NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 5:501-509.
42. Maldonado R (1997) Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev 21:91-104.
43. Middlemas DS, Lindberg RA, Hunter T (1991) trkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol Cell Biol 11:143-153.
44. Minichiello L, Korte M, Wolfer D, Kuhn R, Unsicker K, Cestari V, Rossi-Arnaud C, Lipp HP, Bonhoeffer T, Klein R (1999) Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24:401-414.
45. Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63.
46. North RA, Williams JT, Surprenant A, Christie MJ (1987) Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci USA 84:5487-5491.
47. Numan S, Lane-Ladd SB, Zhang L, Lundgren KH, Russell DS, Seroogy KB, Nestler EJ (1998) Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal. J Neurosci 18:10700-10708.
48. Osborne PB, Williams JT (1996) Forskolin enhancement of opioid currents in rat locus coeruleus neurons. J Neurophysiol 76:1559-1565.
49. Patterson SL, Pittenger C, Morozov A, Martin KC, Scanlin H, Drake C, Kandel ER (2001) Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase. Neuron 32:123-140.
50. Punch LJ, Self DW, Nestler EJ, Taylor JR (1997) Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J Neurosci 17:8520-8527.
51. Riccio A, Pierchala BA, Ciarallo CL, Ginty DD (1999) Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286:2358-2361.
52. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan R, Jaenisch R (2001) Conditional deletion of BDNF in the postnatal brain results in obesity and hyperactivity. Mol Endocrinol 15:1748-1757.
53. Saiepour MH, Semnanian S, Fathollahi Y (2001) Occurrence of morphine tolerance and dependence in the nucleus paragigantocellularis neurons. Eur J Pharmacol 411:85-92.
54. Sklair-Tavron L, Nestler EJ (1995) Opposing effects of morphine and the neurotrophins, NT-3, NT-4, and BDNF, on locus coeruleus neurons in vitro. Brain Res 702:117-125.
55. Soriano P (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70-71.
56. Takeda J, Maekawa T, Sudo T, Seino Y, Imura H, Saito N, Tanaka C, Ishii S (1991) Expression of the CRE-BP1 transcriptional regulator binding to the cyclic AMP response element in central nervous system, regenerating liver, and human tumors. Oncogene 6:1009-1014.
57. Tessarollo L, Parada LF (1995) In situ hybridization. Methods Enzymol 254:419-430.
58. Tinti C, Conti B, Cubells JF, Kim KS, Baker H, Joh TH (1996) Inducible cAMP early repressor can modulate tyrosine hydroxylase gene expression after stimulation of cAMP synthesis. J Biol Chem 271:25375-25381.
59. Tsao P, Cao T, von Zastrow M (2001) Role of endocytosis in mediating downregulation of G-protein-coupled receptors. Trends Pharmacol Sci 22:91-96.
60. Van Bockstaele EJ, Saunders A, Commons KG, Liu XB, Peoples J (2000) Evidence for coexistence of enkephalin and glutamate in axon terminals and cellular sites for functional interactions of their receptors in the rat locus coeruleus. J Comp Neurol 417:103-114.
61. Washton AM, Resnick RB (1983) Recent advances in opiate detoxification: clonidine and lofexidine. NIDA Res Monogr 43:44-50.
62. Watson FL, Heerssen HM, Moheban DB, Lin MZ, Sauvageot CM, Bhattacharyya A, Pomeroy SL, Segal RA (1999) Rapid nuclear responses to target-derived neurotrophins require retrograde transport of ligand-receptor complex. J Neurosci 19:7889-7900.
63. Widnell KL, Russell DS, Nestler EJ (1994) Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc Natl Acad Sci USA 91:10947-10951.
64. Williams JT, North RA, Tokimasa T (1988) Inward rectification of resting and opiate-activated potassium currents in rat locus coeruleus neurons. J Neurosci 8:4299-4306.
65. Williams JT, Christie MJ, Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343.
66. Yacoubian TA, Lo DC (2000) Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth. Nat Neurosci 3:342-349.
67. Yamuy J, Sampogna S, Chase MH (2000) Neurotrophin-receptor immunoreactive neurons in mesopontine regions involved in the control of behavioral states. Brain Res 866:1-14.
68. Zachariou V, Thome J, Parikh K, Picciotto MR (2000) Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal. Neuropsychopharmacology 23:127-137.
69. Zhu H, Zhou W (2001) Morphine induces synchronous oscillatory discharges in the rat locus coeruleus. J Neurosci 21:RC179(1-5).